Articles

1. Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers

   • Christoph Straube
   • Stephanie E. Combs
   • David Kaul

   Research Open access 23 March 2024

   

2. Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

   • Carrie E. Andrews
   • Jenny Zilberberg
   • David W. Andrews

   Correction Open access 22 March 2024 Pages: 369 - 369

3. Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis

   • Peter G. Zaki
   • Sanjeev Herr
   • Matthew J. Shepard

   Correspondence 22 March 2024 Pages: 363 - 364

4. Palliative care for in-patient malignant glioma patients in Germany

   • Larissa Fink
   • Birgitt van Oorschot
   • Marcel A. Kamp

   Research Open access 20 March 2024 Pages: 323 - 338

   

5. Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition

   • Wietse Geens
   • Nathalie Vanlaer
   • Johnny Duerinck

   Case Study 19 March 2024

   

6. Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response

   • Samuel A. Bobholz
   • Alisha Hoefs
   • Peter S. LaViolette

   Correction Open access 18 March 2024 Pages: 243 - 243

7. Comment on “Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control’’

   • Minqi Wang
   • Minqiang Chen
   • Yumei Ge

   Correspondence 18 March 2024

8. The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database

   • Ping Zhu
   • Pavel S. Pichardo-Rojas
   • Yoshua Esquenazi

   Research 16 March 2024

   

9. Correction to: Prognostic factors analysis of diffuse midline glioma

   • Jing Jiang
   • Wen-bin Li
   • Shao-wen Xiao

   Correction Open access 15 March 2024 Pages: 293 - 293

10. Correction to: Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients

    • Sachiv Chakravarti
    • Cathleen C. Kuo
    • Debraj Mukherjee

    Correction 15 March 2024

11. Effects of cognitive-motor intervention for pediatric posterior fossa tumor survivors: results of a pilot study

    • Vladimir N. Kasatkin
    • Elizaveta N. Romanova
    • Alexander F. Karelin

    Research 15 March 2024

    

12. About the incompleteness of our models

    • Didier Wion

    Correspondence 12 March 2024

13. The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study

    • Vincenzo Di Nunno
    • Giuseppe Lombardi
    • Enrico Franceschi

    Research 08 March 2024 Pages: 145 - 154

    

14. Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis

    • Lucca B. Palavani
    • Guilherme Melo Silva
    • Wellingson Paiva

    Review 08 March 2024

    

15. Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis

    • Thomas Graillon
    • Betty Salgues
    • Olivier Chinot

    Research 07 March 2024

    

16. Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review

    • Eric Singh
    • Muhammet Enes Gurses
    • Ashish H. Shah

    Correction 06 March 2024 Pages: 49 - 49

17. Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma

    • Kiyotaka Yokogami
    • Takashi Watanabe
    • Hideo Takeshima

    Research Open access 06 March 2024

    

18. Correction to: The effectiveness and safety of proton beam radiation therapy in children and young adults with Central Nervous System (CNS) tumours: a systematic review

    • Jayne S. Wilson
    • Caroline Main
    • Barry Pizer

    Correction Open access 05 March 2024 Pages: 35 - 37

19. Impact of trametinib on the neuropsychological profile of NF1 patients

    • Eve Lalancette
    • Édith Cantin
    • Sarah Lippé

    Research 05 March 2024

    

20. Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors

    • Andrew B. Barbour
    • Barbara Blouw
    • Jonathan T. Yang

    Case Study 05 March 2024

    

21. Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1

    • Brianna C. Peacock
    • Sanjna Tripathy
    • Anisha B. Patel

    Case Study 05 March 2024

    

22. Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly

    • Mei Luo
    • Jiangfan Yu
    • Rui Tang

    Research 05 March 2024

    

23. Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomas

    • Mark A. Davison
    • Daniel T. Lilly
    • Lilyana Angelov

    Research Open access 04 March 2024

    

24. Preoperative patient-reported physical health-related quality of life predicts short-term postoperative outcomes in brain tumor patients

    • Sachiv Chakravarti
    • Cathleen C. Kuo
    • Debraj Mukherjee

    Research 04 March 2024

    

25. Clinical characteristics and predictive factors of delayed diagnosis in patients with sellar germ cell tumors

    • Tao Tong
    • Han Chen
    • Liyong Zhong

    Research 04 March 2024

    

26. Effect of sarcopenia and frailty on outcomes among patients with brain metastases

    • Mervyn Jun Rui Lim
    • Zheting Zhang
    • Tseng Tsai Yeo

    Case Study 02 March 2024 Pages: 169 - 180

    

27. Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers

    • Kanji Nakagawa
    • Koji Takano
    • Hideyuki Arita

    Research 02 March 2024

    

28. Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review

    • Yasuhito Kegoya
    • Yoshihiro Otani
    • Isao Date

    Case Study Open access 01 March 2024 Pages: 201 - 210

    

29. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors

    • James L. Rogers
    • Thomas Wall
    • Marta Penas-Prado

    Case Study Open access 01 March 2024 Pages: 349 - 359

30. CPLX2 is a novel tumor suppressor and improves the prognosis in glioma

    • Yuanbing Chen
    • Jieling Ning
    • Jun Huang

    Research 01 March 2024 Pages: 63 - 74

    

31. The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study

    • Meimei Yu
    • Ying Ge
    • Huicong Shen

    Research 29 February 2024 Pages: 305 - 313

    

32. Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery

    • Santiago Cepeda
    • Sergio García-García
    • Rosario Sarabia

    Research 28 February 2024

    

33. Diverse learners: learning disabilities and quality of life following mind–body and health education interventions for adults with neurofibromatosis

    • Millan R. Kanaya
    • Jonathan Greenberg
    • Ana-Maria Vranceanu

    Research 27 February 2024 Pages: 315 - 322

    

34. Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence

    • Mohamed Jalloh
    • Samuel Berchi Kankam

    Correspondence 23 February 2024 Pages: 365 - 367

35. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

    • Melek Tugce Yilmaz
    • Alper Kahvecioglu
    • Faruk Zorlu

    Research Open access 22 February 2024 Pages: 295 - 303

    

36. Prognostic factors analysis of diffuse midline glioma

    • Jing Jiang
    • Wen-bin Li
    • Shao-wen Xiao

    Research Open access 21 February 2024 Pages: 285 - 292

    

37. Validation of a methylation-based signature for subventricular zone involvement in glioblastoma

    • Felix Ehret
    • Oliver Zühlke
    • David Kaul

    Research Open access 20 February 2024 Pages: 89 - 97

    

38. The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab

    • Pushan Dasgupta
    • Alexander Ou
    • Nazanin K. Majd

    Case Study 19 February 2024 Pages: 181 - 188

    

39. Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma

    • Phioanh Leia Nghiemphu
    • Jeremie Vitte
    • Marco Giovannini

    Case Study Open access 19 February 2024 Pages: 339 - 348

    

40. Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes

    • Thais Baccili Cury Megid
    • Zeynep Baskurt
    • Elena Elimova

    Research Open access 19 February 2024 Pages: 111 - 122

    

41. Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response

    • Samuel A. Bobholz
    • Alisha Hoefs
    • Peter S. LaViolette

    Research Open access 19 February 2024 Pages: 233 - 241

    

42. Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery

    • Motoyuki Umekawa
    • Yuki Shinya
    • Nobuhito Saito

    Research Open access 18 February 2024 Pages: 51 - 61

    

43. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma

    • Jason P. Sheehan
    • Georgios Mantziaris
    • Adomas Bunevicius

    Correspondence 16 February 2024 Pages: 231 - 232

44. Stereotactic radiosurgery for intracranial adenoid cystic carcinoma

    • Jason P. Sheehan
    • Raj Singh
    • Daniel M. Trifiletti

    Correspondence 16 February 2024 Pages: 229 - 230

    

45. Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors

    • Lisa M. Arnold
    • Yoji Hoshina
    • Joe Mendez

    Case Study 16 February 2024 Pages: 211 - 217

    

46. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma

    • Yukina Shirai
    • Toshihide Ueno
    • Shinji Kohsaka

    Research Open access 16 February 2024 Pages: 75 - 88

    

47. Correction to: CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization

    • Manali Ranade
    • Sridhar Epari
    • Tejpal Gupta

    Correction 15 February 2024 Pages: 199 - 199

48. Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection

    • David Wasilewski
    • Julia Onken
    • Philip Bischoff

    Research Open access 15 February 2024 Pages: 155 - 167

    

49. The role of spine stereotactic radiosurgery for patients with breast cancer metastases

    • Suchet Taori
    • Samuel Adida
    • Peter C. Gerszten

    Research 14 February 2024 Pages: 257 - 266

    

50. Comment: Additional factors affecting cognitive function in low grade glioma patients

    • Polina Angelova
    • Maria Gicheva

    Correspondence 13 February 2024 Pages: 361 - 362